上 海 瑞 狮 生 物 科 技 有 限 公 司
Shanghai RuiShi Biological Technology Co.Ltd
快速查找:
矫形鞋垫
导航菜单
联系我们
公司名称:
上海瑞狮生物科技有限公司
邮箱: sales@ruishihealthcare.com

 
 




CVLT3加利福尼亚言语学习测试第三版- CVLT-C加利福尼亚言语学习测试儿童版
 
CVLT3加利福尼亚言语学习测试第三版(California Verbal Learning Test Third Edition,CVLT3)是对大龄青少年和成年人言语学习和记忆的全面的评估。在CVLT 3测试中,考生听听一系列词语,然后被要求回忆这些词语所属的术语和类别。
开发者:Dean C. Delis;Edith Kaplan ;Joel H. Kramer ;Beth A. Ober
发布年份:2017年
测试年龄范围:16岁至90岁
完成时间:标准和间隔形式:30分钟,外加30分钟延迟间隔
管理:纸笔测试,或基于Q-interactive®的数字形式
评分可选项:Q-Global ®
资质等级:C
CVLT加利福尼亚言语学习测试(California Verbal Learning)被认为是情景性言语学习最敏感的衡量标准之一。
益处
  • 用于评估被诊断患有创伤性脑损伤 (TBI)、痴呆(dementia)、精神分裂症(schizophrenia)、多动症(ADHD)或神经系统疾病的个体。
  • 测试个人重返工作岗位、进行复杂的日常生活活动和独立生活的程度。
  • 评估努力不足或弄虚作假装病,以减少错误结果。
特点
  • 受试者会阅读一份根据多个人口统计学变量的使用频率精心选择的词汇列表,并被要求在后续一系列的试验中回忆这些词汇。
  • 标准和间隔表格可在30分钟内完成测试,延迟评分可额外施测30分钟。
  • 简短记录表格的特点是列出三个类别的九个词语,可以在15分钟内完成。
  • 规范已基于教育、地区、种族和年龄的全面再标准化。
  • 附加分数,对错误(侵入和重复)进行更深入的分析。
  • 升级和更新了纸质版Q-global的评分和报告。
CVLT3加利福尼亚言语学习测试第三版,完整套装,型号:9780158009902,包括:
指导手册、25份标准记录表格和25份间隔记录表格。

  • 请仔细阅读以下本产品重要说明。
本产品重要说明:
  • 语言:英文
  • 计分表格:纸张
  • 国际惯例:相应的专业人员购买并使用
  • 产品主要参数:CVLT3(California Verbal Learning Test Third Edition)
  • 原装进口,产地英国
  • 尊重并维护知识产权,请按以下列表选择购买使用量表类产品,以实现教学、科研等工作的严谨性和信效度
套装    
9780158009902 CVLT3加利福尼亚言语学习测试第三版,完整套装 电邮询价
表格(量表)    
9780158009926 CVLT3加利福尼亚言语学习测试第三版,标准记录表格(一包25份) 电邮询价
9780158009957 CVLT3加利福尼亚言语学习测试第三版,间隔记录表格(一包25份) 电邮询价
9780158009964 CVLT3加利福尼亚言语学习测试第三版,简短记录表格(一包25份) 电邮询价
手册    
9780158009919 CVLT3加利福尼亚言语学习测试第三版,指导手册 电邮询价
 
CVLT-C加利福尼亚言语学习测试儿童版
 
CVLT-C加利福尼亚言语学习测试儿童版(California Verbal Learning Test Children's Version
CVLT-C),用于评估可能因创伤性脑损伤或轻度至重度学习障碍、注意力缺陷障碍、智力障碍、精神问题或其他神经系统疾病而导致学习和记忆障碍的儿童和青少年的言语学习和记忆能力。在各种环境下可用于识别学习和记忆困难、分析有缺陷的学习策略并协助设计补救计划。
开发者:Dean C. Delis;Edith Kaplan;Joel H. Kramer;Beth A. Ober
出版日期:1994年
年龄范围:5至16岁11个月
完成时间:15 ~ 20分钟,间隔20分钟,以适应延迟回忆测量
规范:根据27 个关键指标的全国标准化年龄样本
系统要求:可选的辅助评分软件,仅与Windows XP兼容。
资质等级:C
益处
  • 识别学习和记忆困难。
  • 分析及隔离出有缺陷的学习策略。
  • 用于设计修复计划或补救措施。
特点
CVLT-C对儿童在回忆测量、学习特征测量、回忆错误区域和对比测量方面的表现进行了详细分析。
  • 记忆任务
  • 干扰任务
  • 进行详细的分析
  • 评分软件(可选),CVLT-C评分助手,带报告编写器(CVLT®-C Scoring Assistant® with Report Writer™)
CVLT-C加利福尼亚言语学习测试儿童版,套装,型号:9780158033952,包括:
指导手册和25份记录表格

  • 请仔细阅读以下本产品重要说明。
本产品重要说明:
  • 语言:英文
  • 计分表格:纸张
  • 国际惯例:相应的专业人员购买并使用
  • 产品主要参数:CVLT-C(California Verbal Learning Test Children's Version)
  • 原装进口,产地英国
  • 尊重并维护知识产权,请按以下列表选择购买使用量表类产品,以实现教学、科研等工作的严谨性和信效度
套装    
9780158033952 CVLT-C加利福尼亚言语学习测试儿童版,完整套装 电邮询价
表格(量表)    
9780158033976 CVLT-C加利福尼亚言语学习测试儿童版,记录表格(一包25份) 电邮询价
手册    
9780158033969 CVLT-C加利福尼亚言语学习测试儿童版,指导手册 电邮询价
 
CVLT加利福尼亚言语学习测试(California Verbal Learning Test),文献索引(部分):
  • J Clin Exp Neuropsychol. 2023 Jul 28:1-15. doi: 10.1080/13803395.2023.2241653. Online ahead of print.
《Comparison of core and process scores on the California Verbal Learning Test-3 for Parkinson's disease and essential tremor patients》
  • Neurotoxicol Teratol. 2023 Nov-Dec:100:107307. doi: 10.1016/j.ntt.2023.107307. Epub 2023 Oct 11.
《Early-life manganese exposure during multiple developmental periods and adolescent verbal learning and memory》
  • Front Psychol. 2022 Aug 25:13:935875. doi: 10.3389/fpsyg.2022.935875. eCollection 2022.
《Effects of age, sex, and education on California Verbal Learning Test-II performance in a Chinese-speaking population》
  • Alcohol Clin Exp Res. 2022 Oct;46(10):1808-1818. doi: 10.1111/acer.14929. Epub 2022 Sep 5.
《Frontoparietal and temporal white matter diffusion MRI in children and youth with prenatal alcohol exposure》
  • Appl Neuropsychol Adult. 2022 Mar-Apr;29(2):252-261. doi: 10.1080/23279095.2020.1742718. Epub 2020 Mar 23.
《Examining independent and combined accuracy of embedded performance validity tests in the California Verbal Learning Test-II and Brief Visuospatial Memory Test-Revised for detecting invalid performance》
  • Front Psychol. 2021 Nov 4:12:749045. doi: 10.3389/fpsyg.2021.749045. eCollection 2021.
《Examining Delayed Recall in Cochlear Implant Users Using the Montreal Cognitive Assessment, California Verbal Learning Test, Third Edition, and Item Specific Deficit Approach: Preliminary Results》
  • Arch Clin Neuropsychol. 2020 Jan 24;35(1):90-104. doi: 10.1093/arclin/acy097.
《Refined Measurement of Verbal Learning and Memory: Application of Item Response Theory to California Verbal Learning Test - Second Edition (CVLT-II) Learning Trials》
  • Brain Imaging Behav. 2020 Oct;14(5):1626-1637. doi: 10.1007/s11682-019-00093-9.
《Acute pediatric traumatic brain injury severity predicts long-term verbal memory performance through suppression by white matter integrity on diffusion tensor imaging》
  • Dev Med Child Neurol. 2020 Feb;62(2):214-220. doi: 10.1111/dmcn.14251. Epub 2019 Apr 25.
《Neurodevelopmental and health-related quality-of-life outcomes in adolescence after surgery for congenital heart disease in infancy》
  • Front Neurosci. 2020 Mar 24:14:173. doi: 10.3389/fnins.2020.00173. eCollection 2020.
《The Brief Form of the California Odor Learning Test 3》
  • Clin Neuropsychol. 2020 Feb;34(2):384-405. doi: 10.1080/13854046.2019.1619838. Epub 2019 Jul 19.
《Robust normative standards for the California Verbal Learning Test (CVLT) ages 60-89: A tool for early detection of memory impairment》
  • Cogn Behav Neurol. 2020 Mar;33(1):16-22. doi: 10.1097/WNN.0000000000000219.
《Identification of Subtle Verbal Memory Deficits in Premanifest Huntington Disease Using the California Verbal Learning Test》
  • Brain Inj. 2020;34(2):245-252. doi: 10.1080/02699052.2019.1686772. Epub 2019 Nov 3.
《Comparing learning performance on the open trial selective reminding test with the California verbal learning test II in traumatic brain injury》
  • Appl Neuropsychol Adult. 2019 Sep-Oct;26(5):488-496. doi: 10.1080/23279095.2018.1448818. Epub 2018 Apr 4.
《Comparing the Open Trial - Selective Reminding Test results with the California Learning Verbal Test II in multiple sclerosis》
  • J Neurol Sci. 2019 May 15:400:104-109. doi: 10.1016/j.jns.2019.03.016. Epub 2019 Mar 19.
《Brief and cost-effective tool for assessing verbal learning in multiple sclerosis: Comparison of the Rey Auditory Verbal Learning Test (RAVLT) to the California Verbal Learning Test - II (CVLT-II)》
  • Appl Neuropsychol Child. 2019 Jul-Sep;8(3):206-212. doi: 10.1080/21622965.2018.1426463. Epub 2018 Feb 7.
《Embedded performance validity indicator for children: California Verbal Learning Test - Children's Edition, forced choice》
  • Appl Neuropsychol Adult. 2019 Mar-Apr;26(2):124-138. doi: 10.1080/23279095.2017.1362561. Epub 2017 Sep 19.
《Comparison of the Buschke Selective Reminding Test and the California Verbal Learning Test - Second Edition in a heterogeneous sample of people with traumatic brain injury》
  • J Speech Lang Hear Res. 2019 Apr 15;62(4):1033-1050. doi: 10.1044/2018_JSLHR-H-18-0125.
《Verbal Learning and Memory in Early-Implanted, Prelingually Deaf Adolescent and Adult Cochlear Implant Users》
  • J Clin Exp Neuropsychol. 2019 Aug;41(6):653-663. doi: 10.1080/13803395.2019.1610160. Epub 2019 May 7.
《A process approach to verbal memory assessment: Exploratory evidence of inefficient learning in women remitted from anorexia nervosa》
  • 资源
特别文献:《Substitution of CVLT–3 Scores for WMS–IV Verbal Paired Associates Scores》(用CVLT3分数代替WMS-IV语言记忆)
Abstract
Score substitution usually is associated with measures of cognitive ability and reserved for unintended administration problems. Score substitution enables clinicians to obtain alternate index scores when standardised test administration has been violated. The WMS–IV introduced a score substitution model that enables clinicians to intentionally use scores from
the CVLT–II instead of Verbal Paired Associates in WMS–IV index scores. This study updates the substitution method, using the CVLT–3. Methods: Participants were 380 adults, ages 16–90, who participated in the CVLT–II/WMS–IV linking study. The CVLT–3 learning, short-, and long-delay recall trials contain the same words and administration as the CVLT–II. All CVLT–II
scores were updated with the current norms derived for the CVLT–3. Results: CVLT–3 scores moderately correlated with WMS–IV VPA and LM subtests, and are consistent with the correlation observed between VPA and LM. Scores from CVLT–3 were scaled to WMS–IV norms using equipercentile equating. Discussion: CVLT–3 substitution for VPA does not presume construct equivalence; the equating reflects a rescaling of CVLT–3 to WMS–IV norms. This substitution model is designed to improve clinicians’ workflow and allows for intentional, a priori, decisions to be made regarding the best memory model for a specific diagnostic hypothesis. Rationale and caveats for use are discussed.
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
相关产品
上海瑞狮生物科技有限公司 Shanghai RuiShi Biological Technology Co., Ltd
版权所有 Copyright(C)2013-2025 沪ICP备15014599号